TNF and inflammatory bowel disease: A slightly increased risk of congenital abnormalities in women with IBD exposed to TNF-α inhibitors compared with unexposed pregnant women with IBD seemed to be suggested from the few studies with controls (Table 2), but the CIs were very broad.